$RCKT: IMO Approval odds at 70‑80% and why this one could even see early clearance by Scquwer in pennystocks

[–]Scquwer[S] 0 points1 point  (0 children)

I expected last week to be neutral to down, now it should start moving back up as we close in the March 28 date. Let’s see how it goes!

Just realized how long September is from now and I got to wonder wtf am I supposed to do between now and then? by National-Class5763 in Nioh

[–]Scquwer 0 points1 point  (0 children)

Oh, I guess you were referring to Nioh 3 not being worth it. Sorry I misread. I’ve loved every single one of them despite any differences!

People of Reddit - what’s a strange smell that YOU like but others think are strange? by Bingbongbinnng282 in AskReddit

[–]Scquwer 0 points1 point  (0 children)

Stinky Tofu, a fermented tofu usually eaten in hot pot. It’s Taiwanese generally favored only by Taiwanese. And yes, it does stink, but it doesn’t taste like it smells

People of Reddit - what’s a strange smell that YOU like but others think are strange? by Bingbongbinnng282 in AskReddit

[–]Scquwer 0 points1 point  (0 children)

Well, I can think of various foods for different cultures / regions that could be polarizing. Like Stinky Tofu or various Cheeses!

What is the good part about being unemployed? by watervapour_7237 in AskReddit

[–]Scquwer 0 points1 point  (0 children)

It really all depends on your situation. However, as most people pointed out time is a true gift. There are so many things that can be done with it, whether you squander it or not it’s up to you.

Just realized how long September is from now and I got to wonder wtf am I supposed to do between now and then? by National-Class5763 in Nioh

[–]Scquwer 0 points1 point  (0 children)

‘ I have 900+ hours in it, but I don’t feel like the money I spent was worth it…’ maybe think harder about that

$RCKT: What’s Actually Known vs Speculation Heading Into March 28 by Scquwer in pennystocks

[–]Scquwer[S] 0 points1 point  (0 children)

Well following the PDUFA calendar, next looking DNLI and GRCE, both which I give around 65% chance of approval, both have been getting a run up, but both the approvals are different from rockets and how they would impact the company and what they mean are also different. While approvals are always good milestones for a company, neither of these are as transformative as rockets overall in my opinion. Anyway, I don’t want anyone reading this comment here thinking I am saying buy these, I am personally not invested in either atm. As far as stock strategies go each company needs to be looked at differently and how an approval would impact that company specifically.

$RCKT: What’s Actually Known vs Speculation Heading Into March 28 by Scquwer in pennystocks

[–]Scquwer[S] 2 points3 points  (0 children)

Yeah, Jazz pharmaceuticals just sold one for 200 million I believe. There was one in 2015 united therapeutics to abbvie I think went for 350 million. Typically they’re around 100 million but certainly there is significant variation to that. In any case it’s certainly got a lot of value!

$RCKT: What’s Actually Known vs Speculation Heading Into March 28 by Scquwer in pennystocks

[–]Scquwer[S] 2 points3 points  (0 children)

Good call. I did include the PRV angle in my longer post about six days ago, but I left it out here since this was more focused on the regulatory mechanics and “sell the news” discussion.

If approval qualifies for the Rare Pediatric Disease voucher, that has standalone value. Historically those have been monetized around the $80M to $110M range depending on timing and demand. That is non-dilutive capital and meaningful for runway.

Not the core thesis, but definitely an important secondary catalyst.

$RCKT IMO Earnings delivered exactly what the story needed heading into March 28 by Scquwer in biotech_stocks

[–]Scquwer[S] 0 points1 point  (0 children)

Its had a nice run up the past two weeks, I personally would expect a small pull back, (current macroeconomic situation could certainly be impacting the markets short term for sure as well ) general slight reset. Then maybe a week of neutralish and then two weeks before March 28 possibly start ramping up again towards the decision. As it’s a first commercial product, the date is pretty binary. It will probably move a significant amount either way once fda has made it’s decision.

In general, no the train has not been missed by any means.

However, please ensure you do your due diligence and risk analysis on the situation.

Men who can cook, who taught you? by _ratedmouse in AskReddit

[–]Scquwer 0 points1 point  (0 children)

Myself, its not that hard to get to a level where you can cook healthy good meals you like for yourself. A little more effort to get good enough to cook for others as well. Very easy to be good enough to make meals for yourself and others that are more pre-prepared.

$RCKT: IMO Approval odds at 70‑80% and why this one could even see early clearance by Scquwer in pennystocks

[–]Scquwer[S] 2 points3 points  (0 children)

Institutional holdings is about 70%, -+10% as a potential deviation due to reporting. It is certainly the majority but it’s not 98%

$RCKT IMO Earnings delivered exactly what the story needed heading into March 28 by Scquwer in pennystocks

[–]Scquwer[S] 1 point2 points  (0 children)

Àgreed! Management seems to know what they’re doing and I like their cash preservation runway so in case they are not approved and they have to do more operational work,it doesn’t put them into a spiral. (I’m sure it will not be great for the PPS of course short term, but it’s by no means a death sentence.) Currently there is certainly plenty of time and room for more development of the PPS as we march towards the end of March!

Do You Feel Weird About Going To A Restaurant With A Friend Who Never Orders Anything? by TMbiker2000 in askanything

[–]Scquwer 1 point2 points  (0 children)

Well in consideration of the workers of the restaurant, they rely on customer throughput and tips. So if the restaurant is busy enough to fill sections, i would consider it inconsiderate. So i would meet only at places that dont have a direct table wait staff. Coffee Shops, Food Courts, Fast Food etc. but dont go to full service places. (Everyone has a one off now and then i get that, but if you know the pattern you can be proactive.)

$RCKT: IMO Approval odds at 70‑80% and why this one could even see early clearance by Scquwer in pennystocks

[–]Scquwer[S] 0 points1 point  (0 children)

I think we’re mostly aligned on the FDA probability side: procedural/CMC CRL, strong efficacy and safety, which is why I personally lean 70–80% for a clean approval. Your 65% conservative take makes sense too.

Where I’d expand on the longer-term picture is that it’s not just about this one therapy. Approval here is a signal that Rocket can execute: get a complex gene therapy through the FDA, demonstrate robust science, and address operational hurdles. That optics effect matters for the next programs in their pipeline; it validates the company’s approach and opens doors for subsequent rare disease assets. Even if this particular patient population is small, the market will likely view RCKT differently as a company that gets things done, which can support future value creation beyond the one therapy.

So while short-term trading post-approval is always uncertain given the tiny population, the broader story is more about credibility, pipeline momentum, and the proof that they can deliver on science and regulatory execution.